Fair value (multi-method)
Four independent methods triangulate what AZN is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$2,001.96
Method range
$36.97 – $2,001.96
median $177.68
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $2,001.96 | +1,079.50% |
| Exit multiple | $168.70 | -0.61% |
| Analyst target | $186.67 | +9.98% |
| Graham number | $36.97 | -78.22% |
- Forward DCF$2,001.96
- Exit multiple$168.70
- Analyst target$186.67
- Graham number$36.97
Stock price
$169.73
FCF / share (TTM)
$2.35
3Y FCF CAGR
20.5%
Fair value @ hist. growth
$319.05
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
12.6%
per year over your projection horizon
Margin of safety 46.8% vs hist-growth DCF
Historical 3Y CAGR
20.5%
Your model implies
12.6%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at 20% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | 12.4% | 10.9% | 9.0% | 6.8% | 4.0% |
| 5.0% | 12.4% | 10.9% | 9.0% | 6.8% | 4.0% |
| 5.8% | 15.3% | 14.0% | 12.6% | 10.9% | 8.9% |
| 6.8% | 18.4% | 17.4% | 16.3% | 15.0% | 13.5% |
| 7.8% | 21.2% | 20.3% | 19.4% | 18.4% | 17.2% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
0.39
Low vs growth
Net debt
$24B
Total debt − cash
Beta
0.23
Vs market benchmark
Frequently asked questions
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.14% TTM
- Dividend Profile1.89% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.